Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
U.S. Securities and Exchange Commission v. Hall et al
Case Number:
3:21-cv-01597
Court:
Nature of Suit:
Judge:
Firms
Government Agencies
-
April 19, 2022
SEC Gets Consent Win For CEO's COVID-19 Product Claims
The U.S. Securities and Exchange Commission's case against a biotechnology firm and its chief executive accused of falsely claiming regulators approved of their disinfectants for fighting COVID-19 has resulted in a civil penalty and a prohibition on trading penny stocks, according to a consent judgment approved by an Ohio federal judge.
-
August 19, 2021
SEC Sues Ohio Company Over COVID-19 Product Claims
The U.S. Securities and Exchange Commission in Ohio federal court accused a company of fooling investors by releasing press statements and social media posts that its disinfectant products, apparently launched to fight COVID-19, had been approved by the federal government.